Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.43 |
| ▸ | ACR | P10323 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10972576 | 0.86 | CYP2C9 (0.59) | CYP2C9PRSS1ACRMAPTLMNA | |
| SCHEMBL10972573 | 0.86 | CYP2C9 (0.59) | CYP2C9PRSS1ACRMAPTLMNA | |
| SCHEMBL10972575 | 0.86 | CYP2C9 (0.59) | CYP2C9PRSS1ACRMAPTLMNA | |
| SCHEMBL3799919 | 0.86 | MEN1 (0.42) | CYP2C9MAPTLMNAALDH1A1MEN1 | |
| SCHEMBL3761254 | 0.86 | MEN1 (0.42) | CYP2C9MAPTLMNAALDH1A1MEN1 | |
| SCHEMBL3761250 | 0.86 | MEN1 (0.42) | CYP2C9MAPTLMNAALDH1A1MEN1 | |
| SCHEMBL9052415 | 0.86 | MEN1 (0.42) | CYP2C9MAPTLMNAALDH1A1MEN1 | |
| SCHEMBL3799918 | 0.86 | MEN1 (0.42) | CYP2C9MAPTLMNAALDH1A1MEN1 | |
| SCHEMBL9052414 | 0.86 | MEN1 (0.42) | CYP2C9MAPTLMNAALDH1A1MEN1 | |
| Fluoride SCHEMBL9841471 | 0.85 | CYP2C9 (0.47) | CYP2C9PRSS1ACRMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180052111-A1 | SUBSTRATES, DEVICES, AND METHODS FOR QUANTITATIVE LIQUID CRYSTAL ASSAYS | PLATYPUS TECHNOLOGIES, LLC | 2018-02-22 | — | — | US | disclosed |
| US-9816147-B2 | Liquid crystal based analyte detection | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-11-14 | — | — | US | disclosed |
| US-9816147-B2 | Liquid crystal based analyte detection | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-11-14 | — | — | US | disclosed |
| US-9797843-B2 | Substrates, devices, and methods for quantitative liquid crystal assays | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-10-24 | — | — | US | disclosed |
| US-9797843-B2 | Substrates, devices, and methods for quantitative liquid crystal assays | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-10-24 | — | — | US | disclosed |
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160274084-A1 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC | 2016-09-22 | — | — | US | disclosed |
| US-7662572-B2 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC. (US) | 2010-02-16 | — | — | US | disclosed |
| US-7651662-B2 | Rubbed substrate surfaces; activation; uniform anchoring of liquid crystals | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-01-26 | — | — | US | disclosed |
| US-20100009344-A1 | LIQUID CRYSTAL BASED ANALYTE DETECTION | PLATYPUS TECHNOLOGIES, LLC (US) | 2010-01-14 | — | — | US | disclosed |
| US-7531366-B2 | Bead based assays using a liquid crystal reporter | PLATYPUS TECHNOLOGIES, LLC (US) | 2009-05-12 | — | — | US | disclosed |
| US-20080268546-A1 | DETECTION OF DNA HYBRIDIZATION ON SURFACES | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-10-30 | — | — | US | disclosed |
| US-20080160539-A1 | Substrates, devices, and methods for cellular assays | PLATYPUS TECHNOLOGIES, LLC (US) | 2008-07-03 | — | — | US | disclosed |
| US-20070178534-A1 | Using liquid crystal support comprising chemotactic and chemokinetic agents to monitor cell migration and invasion; diagnosing cancer | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-08-02 | — | — | US | disclosed |
| US-20070099249-A1 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-05-03 | — | — | US | disclosed |
| US-20070042505-A1 | Liquid crystal based analyte detection | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-02-22 | — | — | US | disclosed |
| US-20070004046-A1 | Detection of analytes | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099249-A1 | Compositions and liquid crystals | FABP5, FABP1, SSB | CYP2C9 3739/4885PRSS1 2095/4885ACR 243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.